Considering that epigenetic alteration precedes gene expression, OPN-induced differentially methylated genes are speculated to have strong potential as epigenetic biomarkers for cancer diagnosis, prognostication and therapeutic interventions. This evidence concerns the gene SPP1 and cancer.